Page 20 - Contract Development News Today

COLUMBUS, Ohio, Nov. 9, 2023 /PRNewswire/ -- Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Developmen...

Vetter Development Service Rankweil successfully completes re-inspectionSuccessful inspection completed at clinical siteInspectors were impressed with systems and processesAustrian site supports manufacturing and quality control of Human Investigational Medicinal ProductsRAVENSBURG, Germany & RANKWEIL, Austria--(BUS...

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active Pharmaceutical Ingredients business (Teva api). Dr. Ananth will lead the API business starting November 27, 2023, and will be base...

The pharma company had reported a net profit of Rs 111.1 crore in the year-ago period.

Teva Pharmaceutical Industries Ltd. today announced the appointment of Dr. R. Ananthanarayanan as CEO of its Teva Active Pharmaceutical Ingredients business . Dr. Ananth will lead the API business...

Teva Pharmaceutical Industries Ltd. today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active Pharmaceutical Ingredients business (Teva api). Dr. Ananth will lead the API business starting November 27, 2023, and...

BioCina Pty Ltd., a global end-to-end biologics contract development and manufacturing organization (CDMO), announced the expansion of their partnership with GPN Vaccines Ltd. GPN Vaccines is a biotechnology company developing a proprietary engineered whole-cell vaccine called Gamma-PN™ against Streptococcus pneumoniae. This bacterium is responsible for causing life-threatening infections such as pneumonia, bacteraemia and meningitis, each year causing up to 2 million deaths worldwide. GP...

/PRNewswire/ -- Genezen, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced the closing of an $18.5...

Pressure BioSciences Patented BaroFold Technology Platform for High ...

LONDON & NEW YORK--(BUSINESS WIRE)--Nov 1, 2023--